1-4 of 4
Claire Quiney
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

p53 Functional Assessment and Correlation with 17p Deletion and/or TP53 Mutation Status: Final Report of the ICLL001 Bomp Trial

Magali Le Garff-Tavernier, Claire Quiney, Lauren Veronese, MD PhD, Florence Nguyen-Khac, MD PhD, Pauline Robbe, MSc, PhD, Patricia Combes, Marie-Sarah Dilhuydy, MD, Pierre Feugier, Beatrice Mahe, MD, Laurence Sanhes, MD, Alain Jacques Delmer, MD, Loic Ysebaert, MD PhD, Malgorzata Truchan-Graczyk, Brigitte Dreyfus, MD, Choquet Sylvain, MD, Thérèse Aurran, MD, Emmanuelle Ferrant, MD, Caroline Dartigeas, MD, Stéphane Leprêtre, MD, Gian Matteo Pica, MD, Frederic Davi, MD PhD, Bruno Pereira, Roselyne Delepine, Anna Schuh, MD PhD, Romain Guieze, MD, Jacques-Olivier Bay, MD PhD, Véronique Leblond, MD PhD, Helene Merle-Beral, MD PhD, Sophie de Guibert, MD, Olivier Tournilhac, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3127.
https://doi.org/10.1182/blood-2018-99-116722
Published: 2018
Journal Articles

RIC Allogeneic Stem Cell Transplantation for High Risk CLL Followed By Preemptive MRD-Based Immunointervention - Final Results from the Phase II ICLL03 Ricac-Pmm Trial (FILO - SFGM-TC French intergroup)

Olivier Tournilhac, MD PhD, Magali Le Garff-Tavernier, Reza Tabrizi, MD, Stephanie Nguyen-Quoc, Faezeh Legrand-Izadifar, Patricia Combes, Patrice Chevallier, MD, Oumedaly Reman, MD, Cecile Tomowiak, MD, Cecile Borel, MD, Sylvie François, Pascal Turlure, Sebastien Maury, MD PhD, Gaelle Guillerm, MD, Laure Vincent, Karin Bilger, Richard Lemal, MD, Romain Guieze, MD PhD, Claire Quiney, Aurelie Cabrespine, PhD, Jacques-Olivier Bay, MD PhD, Veronique Leblond, Nathalie Dhedin, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4599.
https://doi.org/10.1182/blood.V130.Suppl_1.4599.4599
Published: 2017
Journal Articles

RIC Allogeneic Stem Cell Transplantation for High Risk CLL Followed By Preemptive MRD-Based Immunointervention - Intermediate Results from the Phase II ICLL03 Ricac-Pmm Trial (FILO & SFGM-TC French intergroup)

Olivier Tournilhac, MD PhD, Magali Le Garff-Tavernier, PharmD, PhD, Reza Tabrizi, MD, Stephanie Nguyen quoc, MD, Faize Legrand-Izadifar, MD, Patrice Chevallier, MD PhD, Oumedaly Reman, MD, Cecile Tomowiak, MD, Cecile Borel, MD, Sylvie Francois, MD, Pascal Turlure, MD, Sébastien Maury, Gaelle Guillerm, MD, Luc Fornecker, MD, Richard Lemal, MD, Claire Quiney, Carole Bellanger, Laure Calvet, MD, Lauren Veronese, MD PhD, Aurelie Cabrespine, PhD, Mathieu Coudert, Jacques-Olivier Bay, MD PhD, Helene Merle-Beral, MD PhD, Nathalie Dhedin, MD
Journal: Blood
Blood (2015) 126 (23): 3222.
https://doi.org/10.1182/blood.V126.23.3222.3222
Published: 2015
Journal Articles

Minimal Residual Disease (MRD) By 8-Color Flow Cytometry (Flow-MRD) and IGH Clonospecific Quantitative PCR (ASO RQPCR) Reached Similar Performances for Evaluation of CLL Treatment in a Phase II Clinical Trial: Cross Validation of the Methods

Remi Letestu, MD PhD, Guillaume Cartron, MD, Stephane Lepretre, MD, Magali Le Garff-Tavernier, PharmD, PhD, Francoise Solly, MD, Lydia Campos, MD PhD, Michel Ticchioni, MD PhD, Claire Quiney, Abdelmalek Dahmani, Marouane Boubaya, Vincent Levy, MD PhD, Florence Cymbalista, MD, Marie-Helene Delfau-Larue, MD PhD
Journal: Blood
Blood (2014) 124 (21): 3307.
https://doi.org/10.1182/blood.V124.21.3307.3307
Published: 2014